Cargando…
Correction for Lebedeva et al., Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173750/ https://www.ncbi.nlm.nih.gov/pubmed/35584122 http://dx.doi.org/10.1073/pnas.2204209119 |
Ejemplares similares
-
Correction to: Response to Juberg et al
por: Mie, Axel, et al.
Publicado: (2020) -
Correction for Lu et al., Screening for gene expression fluctuations reveals latency-promoting agents of HIV
Publicado: (2022) -
Correction for Guo et al., Quantitative, in situ visualization of intracellular insulin vesicles in pancreatic beta cells
Publicado: (2022) -
Correction: Lin et al. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma. Cancers 2021, 13, 3367
por: Lin, Min, et al.
Publicado: (2021) -
Correction to: reply to Woodley of Menie et al.
por: Arslan, Ruben C., et al.
Publicado: (2018)